Literature DB >> 21684261

Endothelial cell-specific aryl hydrocarbon receptor knockout mice exhibit hypotension mediated, in part, by an attenuated angiotensin II responsiveness.

Larry N Agbor1, Khalid M Elased, Mary K Walker.   

Abstract

Hypotension in aryl hydrocarbon receptor knockout mice (ahr(-/-)) is mediated, in part, by a reduced contribution of angiotensin (Ang) II to basal blood pressure (BP). Since AHR is highly expressed in endothelial cells (EC), we hypothesized that EC-specific ahr(-/-) (ECahr(-/-)) mice would exhibit a similar phenotype. We generated ECahr(-/-) mice by crossing AHR floxed mice (ahr(fx/fx)) to mice expressing Cre recombinase driven by an EC-specific promoter. BP was assessed by radiotelemetry prior to and following an acute injection of Ang II or chronic treatment with an angiotensin converting enzyme inhibitor (ACEi). ECahr(-/-) mice were hypotensive (ECahr(+/+): 116.1±1.4; ECahr(-/-): 107.4±2.0 mmHg, n=11, p<0.05) and exhibited significantly different responses to Ang II and ACEi. While Ang II increased BP in both genotypes, the increase was sustained in ECahr(+/+), whereas the increase in ECahr(-/-) mice steadily declined. Area under the curve analysis showed that Ang II-induced increase in diastolic BP (DBP) over 30 min was significantly lower in ECahr(-/-) mice (ECahr(+/+) 1297±223 mmHg/30 min; ECahr(-/-)(AUC): 504±138 mmHg/30 min, p<0.05). In contrast, while ACEi decreased BP in both genotypes, the subsequent rise in DBP after treatment was significantly delayed in the ECahr(-/-) mice. ECahr(-/-) mice also exhibited reduced vascular and adipose Ang II type 1 receptor (AT1R) expression, and reduced aortic Ang II-dependent vasoconstriction in the presence of vascular adipose. Taken together these data suggest that hypotension in ECahr(-/-) mice results from reduced vascular responsiveness to Ang II that is influenced by AT1R expression and adipose.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684261      PMCID: PMC3148414          DOI: 10.1016/j.bcp.2011.06.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  52 in total

1.  Co-expression of renin-angiotensin system genes in human adipose tissue.

Authors:  S Engeli; K Gorzelniak; R Kreutz; N Runkel; A Distler; A M Sharma
Journal:  J Hypertens       Date:  1999-04       Impact factor: 4.844

2.  2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus.

Authors:  A Poland; E Glover
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

3.  Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide.

Authors:  Y-J Gao; C Lu; L-Y Su; A M Sharma; R M K W Lee
Journal:  Br J Pharmacol       Date:  2007-03-26       Impact factor: 8.739

4.  Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.

Authors:  F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

5.  Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.

Authors:  C R Esther; T E Howard; E M Marino; J M Goddard; M R Capecchi; K E Bernstein
Journal:  Lab Invest       Date:  1996-05       Impact factor: 5.662

6.  Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress.

Authors:  Daniel E Conway; Yumiko Sakurai; Daiana Weiss; J David Vega; W Robert Taylor; Hanjoong Jo; Suzanne G Eskin; Craig B Marcus; Larry V McIntire
Journal:  Cardiovasc Res       Date:  2009-01-06       Impact factor: 10.787

Review 7.  The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems.

Authors:  Brian J McMillan; Christopher A Bradfield
Journal:  Mol Pharmacol       Date:  2007-05-29       Impact factor: 4.436

8.  Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide.

Authors:  Rien van Haperen; Monique de Waard; Elza van Deel; Barend Mees; Michael Kutryk; Thijs van Aken; Jaap Hamming; Frank Grosveld; Dirk J Duncker; Rini de Crom
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

9.  Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

Authors:  D E Vaughan; S A Lazos; K Tong
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow.

Authors:  P A Koni; S K Joshi; U A Temann; D Olson; L Burkly; R A Flavell
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  20 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

2.  Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection.

Authors:  Jennifer L Head Wheeler; Kyle C Martin; B Paige Lawrence
Journal:  J Immunol       Date:  2012-12-10       Impact factor: 5.422

3.  Role of CYP1A1 in modulating the vascular and blood pressure benefits of omega-3 polyunsaturated fatty acids.

Authors:  Larry N Agbor; Elani F Wiest; Michael Rothe; Wolf-Hagen Schunck; Mary K Walker
Journal:  J Pharmacol Exp Ther       Date:  2014-10-14       Impact factor: 4.030

4.  Elevated blood pressure in cytochrome P4501A1 knockout mice is associated with reduced vasodilation to omega-3 polyunsaturated fatty acids.

Authors:  Larry N Agbor; Mary T Walsh; Jason R Boberg; Mary K Walker
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-18       Impact factor: 4.219

5.  Do endothelial cells eat tryptophan to die?

Authors:  Charity Duran; Alejandra San Martín
Journal:  Circ Res       Date:  2014-01-31       Impact factor: 17.367

6.  The activation of the kynurenine pathway in a rat model with renovascular hypertension.

Authors:  Jacek Bartosiewicz; Tomasz Kaminski; Krystyna Pawlak; Malgorzata Karbowska; Anna Tankiewicz-Kwedlo; Dariusz Pawlak
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

7.  Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension.

Authors:  Jordan Kho; Xiaoyu Tian; Wing-Tak Wong; Terry Bertin; Ming-Ming Jiang; Shan Chen; Zixue Jin; Oleg A Shchelochkov; Lindsay C Burrage; Anilkumar K Reddy; Hong Jiang; Reem Abo-Zahrah; Shuangtao Ma; Ping Zhang; Karl-Dimiter Bissig; Jean J Kim; Sridevi Devaraj; George G Rodney; Ayelet Erez; Nathan S Bryan; Sandesh C S Nagamani; Brendan H Lee
Journal:  Am J Hum Genet       Date:  2018-08-02       Impact factor: 11.025

Review 8.  AHR in the intestinal microenvironment: safeguarding barrier function.

Authors:  Brigitta Stockinger; Kathleen Shah; Emma Wincent
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-19       Impact factor: 46.802

Review 9.  Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease.

Authors:  Jonathan D Ravid; Mohamed Hassan Kamel; Vipul C Chitalia
Journal:  Nat Rev Nephrol       Date:  2021-03-23       Impact factor: 28.314

10.  Transcriptional Regulation of Drug Metabolizing CYP Enzymes by Proinflammatory Wnt5A Signaling in Human Coronary Artery Endothelial Cells.

Authors:  Tom Skaria; Esther Bachli; Gabriele Schoedon
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.